Peroxidation of lipids in blood and tissues may be involved in degenerative processes associated with chronic diseases such as atherosclerosis (Steinberg et al. 1989) . It is therefore pertinent to study lipid peroxidation in vivo, especially factors that may affect the rate of peroxidation. Although the mechanism of lipid peroxidation in vivo is not fully understood, it has been suggested that free Fe may catalyse its initiation (Kanner et al. 1988; Halliwell & Chirico, 1993) . In biological systems, Fe is not free, but bound to biomolecules such as the proteins transferrin, haemoglobin, and ferritin. Mobilisation of Fe from these biomolecules may be required before it can catalyse lipid peroxidation. In vitro experiments suggest that this may occur under certain conditions such as presence of protonating, chelating, or reducing agents including ascorbic acid (Aust, 1987; Gutteridge, 1987) . It is uncertain whether Fe mobilisation occurs in vivo, whether ascorbic acid is involved, and whether mobilised Fe is subsequently engaged in pro-oxidant activity. Epidemiological observations, however, associate high-Fe stores with heart disease (Salonen et al. 1992) . Moreover, it has been suggested that large doses of ascorbic acid may be detrimental to haemochromatosis patients (Herbert, 1983) . It is therefore important to elucidate the role of ascorbic acid under the conditions of Fe overload in order to better understand the behaviour of ascorbic acid toward oxidation.
The objective of this present study was to test the hypothesis that large doses of ascorbic acid may mobilise Fe from biomolecules in vivo thus promoting in vitro lipid peroxidation in serum, particularly in LDL, in Fe-loaded animals.
Materials and methods

Study protocol
The study protocol was approved by the Institutional Animal Care and Use Committee at Cornell University.
Eighteen male guinea pigs (Hartley strain; Camm Research Institute, Wayne, NJ, USA), weighing about 500 g on arrival, aged 3±5 months, were housed individually in suspended stainless-steel cages with wire-mesh bottoms in a humidity-and temperature-controlled room with a 12 h light±dark cycle. The animals had free access to distilled water and a commercial guinea-pig diet (Prolab Guinea Pig Formula; Agway Inc., Syracuse, NY, USA) throughout the study (Table 1) . The guinea pigs were allocated to two groups of nine animals each so that each group had similar mean body weights. The groups were assigned randomly to either the control or the Fe-loaded group. The procedures of the experiment were as follows (Table 2) . On days 1 and 5, each animal from the Fe-loaded group received an intraperitoneal (i.p.) injection of 200 mg Fe as iron dextran (100 mg Fe/ml; Butler, Colombus, OH, USA). One week later, on day 12, all animals were deprived of food for 8 h and then given 1 ml saline i.p. injection. They were anaesthetised 4 h later with an injection of 9 mg Ketamine-HCl and 0´1 mg Acepromazine (Ft. Dodge Animal Health, Fort Dodge, IA, USA) and kept under anaesthesia with Methoxyflurane (Schering-Plough Animal Health Corp., Union, NJ, USA). Blood (6 ml) was collected from each animal by cardiac puncture. Five ml were delivered into EDTA-containing tubes (2 mg EDTA/ ml) on ice, and 1 ml to clean tubes, on ice, for plasma and serum separation, respectively. While still under anaesthesia, animals from the control group received an i.p. injection of 3 mg Fe as iron dextran to replace Fe withdrawn in the blood. Animals from the Fe-loaded group received another i.p. injection of 200 mg Fe as iron dextran. A week later, on day 19, all animals were deprived of food for 8 h and then injected i.p. with 75 mg ascorbic acid in 1 ml saline. Blood (6 ml) was collected from each animal as on day 12.
Analytical techniques
All chemicals were from Sigma Chemical Co. (St Louis, MO, USA) except for thiobarbituric acid, which was from Kodak (Rochester, NY, USA). Iron dextran was from Fisons Corporation (Rochester, NY, USA). Bleomycin (Bleoxane R ) was a gift of Bristol-Myers Squibb (Princeton, NJ, USA). Analyses in serum were performed on fresh samples. LDL preparation and analyses were completed within 4 d after blood collection on the same time schedule as for blood collected on days 12 and 19.
Serum was obtained by centrifugation of blood collected into clean tubes at 1000 g for 15 min at 48C. Plasma was obtained by centrifugation of blood treated with EDTA, as described. LDL d 1´019±1´063 gaml was isolated by sequential ultracentrifugation of plasma. Briefly, 3 ml plasma of density adjusted to 1´019 g/ml with 84 ml NaBr, 1´470 g/ml, was made to 6´05 ml with NaBr, 1´019 g/ml, and centrifuged at 180 000 g at 48C for 18 h in a Beckman (Beckman-Coulter Inc, Fullerton, CA, USA) 50´3 rotor. The lower fraction (4 ml) was recovered, brought to 5´50 ml with NaBr, 1´019 g/ml, and adjusted to a density of 1´063 g/ml with 0´595 ml NaBr, 1´470 g/ml. After another 14 h centrifugation at 180 000 g at 48C, the top fraction (2 ml), was collected and dialysed in EDTAwashed dialysis tubing (Spectra/Pore, Fisher Scientific, Pittsburgh, PA, USA), molecular mass cut-off 12 000± 14 000 Da) against 4 litres of cold PBS, pH 7´4, in the dark for 10 h. Dialysis was repeated for a second time with fresh PBS. Protein content of LDL fractions, determined with the Food was withdrawn Food was withdrawn After 8 h, 1 ml saline was injected i.p.
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Peterson-Lowry method (Sigma Kit P-5656), was adjusted to 75 mg/ml with PBS. Total serum Fe and transferrin saturation were determined (Sigma kit 565-B). In serum, bleomycin-reactive Fe referred herein as`loosely-bound Fe' was determined according to Simpson et al. (1992) with the bleomycin assay (Gutteridge & Hou, 1986; Gutteridge & Halliwell, 1987) . The term`loosely-bound iron' refers to ionic or weakly chelated Fe capable of complexing with bleomycin, an antitumour drug. The Fe±bleomycin complex is highly reactive and cleaves DNA releasing thiobarbituric acid reactive substances (TBARS). Briefly, 0´5 ml 1 mg/ml DNA (calf thymus, treated with Chelex resin (0´3 g/ml), pH 7, 0´1 ml bleomycin sulfate (0´5 g/l), 0´1 ml 50 mMMgCl 2 , 0´1 ml 0´3 M-KH 2 PO 4 ±KOH, pH 7´4 (treated with Chelex resin (0´4 g/ml)), 0´1 ml sample, and 0´1 ml 7´5 mM-ascorbic acid (treated with Chelex resin (0´4 g/ml) and titrated with dichlorophenolindophenol) were mixed in the order listed and incubated for 1 h at 378C. Standards were prepared from a ferric iron solution (atomic absorption standard) in 0´01 M-HCl (Chelex treated). The final concentrations were 0´5 mg DNA/ml, 0´05 mg bleomycin/ ml, 5 mM-MgCl 2 , 30 mM-buffer and 0´75 mM-ascorbic acid. To determine TBARS, 0´1 ml 0´1 M-EDTA, 1 ml thiobarbituric acid (10 g/l) and 1 ml 3 mM-HCl were added to each sample and control. The mixture was heated for 10 min at 1008C in a boiling-water bath. After the samples cooled, they were centrifuged at 2000 g for 10 min and the absorbance of the supernatant fraction was read at 532 nm. The precision of the method may be evaluated from the correlation coefficient of the standard curve (r 0´975) and CV of duplicate measurements on serum samples (4´44 %) .
Lipid peroxidation in serum was determined as TBARS. Serum (0´1 ml) and PBS (0´4 ml), were mixed with 1 ml thiobarbituric acid (6´7 g/l) and 1 ml TCA (200 g/l) and heated at 1008C for 30 min. TBARS were extracted with 2 ml butanol and assayed fluorometrically with excitation at 515 nm and emission at 553 nm. Standards were prepared from tetraethoxypropane, which yields malondialdehyde, in PBS. TBARS were expressed as`nmol malondialdehyde equivalents'. Susceptibility of LDL to in vitro oxidation was estimated in LDL samples incubated at 378C for 24 h in the presence of 5 mM-CuSO 4 . Oxidation was expressed as the increase in concentration of TBARS or conjugated dienes in a 24 h period. Briefly, for the TBARS assay, 0´5 ml LDL containing 37´5 mg protein were mixed with 1 ml thiobarbituric acid (6´7 g/l) and 1 ml TCA (200 g/l) and treated as described for the serum samples. The precision of the method may be evaluated from correlation coefficient of the standard curve (r 0´997) . For the conjugated diene assay, 1 ml LDL containing 75 mg protein was mixed with 0´5 mM-CuSO 4 to give a final concentration of 5 mMCuSO 4. . Conjugated diene concentration was monitored at 234 nm (Steinbrecher et al. 1984) . The precision of the method may be evaluated from correlation coefficient of the standard curve (r 0´994) .
Statistical analysis. Unpaired comparisons between the control and the Fe-loaded group were done with the MannWhitney test (rank sum test for two independent samples).
Paired comparisons for data collected before and after the ascorbic acid injections were performed with the Wilcoxon sign-rank test. (Snedecor & Cochran, 1980) . The CI was 95 %.
Results
Serum Fe concentration and transferrin saturation were determined to assess Fe status (Table 3 ). Both indices were higher for the Fe-loaded group compared with the control throughout the experiment P , 0´050X Treatments on day 12 did not produce any significant change in serum Fe or transferrin saturation within the control or the Fe-loaded group P . 0´050X These results indicate that an Fe-loaded state was induced successfully and that there was no further change to the Fe status of either group throughout the experimental period.
The body weights of the animals were recorded at various time points throughout the experiment (Table 4) . Mean values within a column were significantly different from other values (Mann-Whitney test for comparisons between the control and the ironloaded group and Wilcoxon sign-rank test for paired comparisons for data collected before and after the ascorbic acid injections, *P , 0´05X ² All guinea pigs had free access to distilled water and a commercial guineapig diet throughout the study (see Table 1 ). Animals from the iron-loaded group were injected intraperitoneally with 200 mg iron dextran on days 1 and 5. All animals were injected intraperitoneally with ascorbic acid on day 19. For details of procedures, see p. 681. Mean values in the control group, were significantly different from values in the iron-loaded group on a given day (unpaired comparisons, Mann-Whitney test) and from values in the same group on day 0 (paired comparison within the same group, Wilcoxon sign-rank test) *P , 0´05X ² All guinea pigs had free access to distilled water and a commercial guineapig diet throughout the study (see Table 1 ). Animals from the iron-loaded group were injected intraperitoneally with 200 mg iron dextran on days 1 and 5. All animals were injected intraperitoneally with ascorbic acid on day 19. Blood (6 ml) was drawn for analysis on days 12 and 19. For details of procedures, see p. 681.
Initially, and on day 7, there was no difference between the two groups P 0´859 and P 0´499 respectively). On days 11 and 19, weights of the animals in the Fe-loaded group were lower than weight of the animals in the control group P 0´018 and P 0´028 respectively). Overall (comparison between day 0 and day 19), the animals in the Fe-loaded group did not grow P 0´398 while the animals in the control did P 0´012X Some individuals seemed to be affected more than others and were examined by a veterinary surgeon. No signs of disease were identified in the examination. However, it appears that stunted growth in the Fe-loaded group is associated with Fe overloading. Loosely-bound Fe ( Fig. 1(a) ) was not different between the two groups on day 12 P 0´186 but increased in the Fe-loaded group after the ascorbic acid injection compared with this group on day 12 P 0´017 or with the control group after the ascorbic acid injection P 0´001X No change was observed in the control group following ascorbic acid injection P 0´498X Lipid peroxidation in serum assessed in vitro as TBARS followed the same pattern ( Fig. 1(b) ), although statistical significance does not allow for equally confident conclusions since P values were barely significant. In particular, TBARS appear no different in the two groups on day 12 P 0´054 but higher in the Fe-loaded group after the ascorbic acid injection, compared with the TBARS in the Fe-loaded group on day 12 P 0´042 or to the TBARS in the control group after the injection P 0´023X No change was observed in the control group following ascorbic acid injection P 0´465X Susceptibility to in vitro oxidation of LDL from the control group was lower than that of LDL from the Feloaded group before the ascorbic acid injection. There was no difference in the susceptibility of LDL to in vitro oxidation between the two groups after the ascorbic acid injection. In particular, incubation of LDL at 378C for 24 h in the presence of CuSO 4 produced higher levels of TBARS in the Fe-loaded group compared with the control group P 0´005Y but only before the ascorbic acid injection. After the injection of ascorbic acid, levels of TBARS increased significantly in the control group P 0´027Y but not in the loaded group P 0´499X There was no difference in TBARS between the control and the Feloaded group after the injections of ascorbic acid P 0´560 (Fig. 1(c) ). Changes in conjugated diene concentration following LDL oxidation in vitro were very similar to those observed with the TBARS test ( Fig. 1(d) ). In particular, differences between the control and the Feloaded group in susceptibility of LDL to in vitro oxidation were observed before the ascorbic acid injection P 0´004 but not after P 0´791X Susceptibility of LDL to in vitro oxidation increased marginally after the injection of ascorbic acid in the control group P 0´046 but not in the Fe-loaded group P 0´260X Discussion Ascorbic acid, as well as other free radical scavengers, may inhibit lipid peroxidation in vivo. In fact, numerous studies suggest that ascorbic acid contributes to antioxidant defences in a plethora of systems in vitro (Frei et al. 1989; Dasgupta & Zdunek, 1992) as well as in vivo in animals (Kunert & Tappel, 1983; Dillard et al. 1984) and in human subjects (Rifici & Khachadurian, 1993) . However, the behaviour of ascorbic acid in in vitro systems that contain high amounts of Fe may be complicated. Ascorbic acid may reduce Fe to the more reactive ferrous form. Moreover, it has been suggested that both ferrous and ferric Fe must be available to initiate lipid peroxidation (Minotti & Aust, 1992) . Therefore, depending on the experimental conditions, ascorbic acid may act as a pro-oxidant in vitro and in vivo when Fe is present (O'Connel et al. 1985; Yamamoto & Niki, 1988; Minotti & Aust, 1992; Casalino et al. 1996) . Observations on the pro-oxidant role of ascorbate in guinea pigs supplemented with high levels of ascorbic acid (Chen & Chang, 1978) have been reported, however, the mechanism by which ascorbic acid exerts its effect in these systems is not known. It has been suggested (Gutteridge et al. 1983 ) that, in in vitro model systems, ascorbic acid may reductively release Fe from biomolecules such as ferritin. This Fe may in turn catalyse lipid peroxidation.
In the present study we report a similar observation in the guinea pig. Our data suggest that ascorbic acid promotes the release of Fe from biomolecules where it is bound. Presumably, some of the released Fe takes the form of ionic Fe or weakly-chelated Fe compounds. This Fe, detectable with the bleomycin assay and referred herein as looselybound Fe, has been associated with oxidative processes. Thus, loosely-bound Fe appears to be Fe that is available to catalyse in vivo oxidation (Gutteridge & Halliwell, 1987) . Ferritin is the likely source of this Fe (Gutteridge et al. 1983) .
Lipid peroxidation measurements performed in vitro in serum suggest that, in the Fe-loaded group, Fe released by ascorbate promotes oxidative processes. Measurements on the susceptibility of LDL to in vitro oxidation, however, are not in full agreement with these results. In particular, oxidation of LDL from Fe-loaded animals was markedly higher than the control in the absence of injected ascorbic acid. When ascorbic acid was injected, oxidation increased in the control but not in the Fe-loaded group (Fig. 1(C) and (D)). This apparent discrepancy may be due to the fact that LDL oxidation had reached a maximum in the preparation from the Fe-loaded animals without the ascorbic acid injections and therefore did not respond to ascorbic acid injection. LDL from the control animals, on the other hand, was quite resistant to oxidation, leaving room for a response when ascorbic acid was injected. This discrepancy in results between serum and LDL may be at least partially explained by differences in the composition of serum and in vitro preparations of LDL. Serum was used untreated and is expected to contain various antioxidant compounds while the in vitro preparation of LDL was obtained through a procedure that involves removal of plasma fractions including, perhaps, antioxidants. It is therefore expected that serum and LDL may respond differently in in vitro tests. Differences in the methodology employed for testing in vitro oxidation are also important in interpreting these data. While oxidation in serum is assessed under mild in vitro conditions, susceptibility of LDL to in vitro oxidation is assessed under harsh conditions of prolonged heating in the presence of a catalyst. It is not surprising that under the challenge of these conditions, the behaviour of the samples was different (Esterbauer et al. 1992) . It follows that if the challenge to oxidation had been done for a shorter time or under less severe conditions, ascorbate addition may have shown an enhancing effect at the Fe-loaded state or at both Fe levels. Literature suggests, however, that trends in susceptibility to in vitro oxidation are similar for long as well as for short periods of incubation under conditions similar to the conditions employed in this study (Parthasarathy et al. 1990; Reaven et al. 1991) . Future time-course studies under various oxidation conditions may provide a further insight into the observed phenomena.
The effect of time on the treatments applied to the animals was not assessed in the current study. The experimental design employed, allows for paired and unpaired comparisons, however, it does not assess time effects since treatments of the animals and analyses of the samples were performed only on selected time points. Specifically, the effects of Fe (alone) and of ascorbate were studied only on days 12 and 19 respectively, and were not followed at various time points throughout the experiment. An alternative experimental design that allows tracking of the effects of treatment as well as of time may provide additional insights.
The animals in both groups appeared healthy throughout the experiment and a veterinary surgeon who examined the animals found no signs of disease. Nevertheless, differences in growth rates between the control and the Fe-loaded group suggest that the Fe loading did affect the health of the animals. The size and frequency of the iron dextran dosing were based on a study reported by Dillard et al. (1984) . In that study, rats were given 1±2 g iron dextran/kg body weight injected i.p. There was no mention of toxic effects in the paper. Therefore, we did not expect a toxic reaction since we injected less iron: 0´8 g/kg body weight given as two injected doses of 0´4 g/kg. Iron dextran is rapidly cleared from the serum (Goldberg & Martin, 1960) , therefore another dose of 0´4 g/kg body weight was given to the Fe-loaded group after the first week.
The dose of ascorbic acid as well as the pattern of the injection and blood drawing was based on a study reported by Kunert & Tappel (1983) . The interpretation of the physiological relevance of this dose is related to the requirement for ascorbic acid of the guinea pig. Depending on diet composition, the dietary requirement is 5±50 mg/kg body weight, i.e. 2´5±25 mg for the average 500 g animal (Poole, 1987) . Thus, the injected 75 mg dose was 3±30 times the requirement.
Our data suggest that ascorbic acid mobilises Fe in vivo and the mobilised Fe catalyses lipid peroxidation assessed in vitro. Although the in vitro tests may reflect in vivo reactions, we cannot conclusively infer that high doses of ascorbic acid lead to in vivo lipid oxidation. However, the present study provides additional support for the hypothesis that high intakes of Fe and/or ascorbic acid could increase in vivo lipid peroxidation of LDL and therefore could increase risk for atherosclerosis. (Sullivan, 1989) . Serum ferritin concentration (Salonen et al. 1992) , serum Fe concentration (Corti et al.1997) , and the serum transferrin receptor ratio: serum ferritin ratio (Tuomainen et al. 1998) , as well as dietary Fe intakes (Tzonou et al. 1998) , are associated with increased risk of myocardial infarction. However, in other studies this positive association between Fe status and atherosclerosis has not been demonstrated (Ascherio et al. 1994; Reunanen et al. 1995) . In the First National Health and Nutrition Examination Survey (NHANES I), serum Fe and transferrin saturation were inversely associated with CHD (Liao et al. 1994) .
In summary, the present study showed that in Fe-loaded guinea pigs, ascorbic acid promotes the release of Fe from biomolecules. Presumably, this loosely-bound Fe was responsible for the observed increase in peroxidation in the serum of Fe-loaded animals injected with ascorbic acid.
The effect on oxidation of isolated LDL particles was different. Ascorbic acid injection increased LDL oxidation in the control but not in the Fe-loaded animals. Perhaps Fe loading caused maximal oxidation of isolated LDL so that the increase in loosely-bound Fe caused by ascorbic acid injection had no further effect. These data support the hypothesis that large doses of ascorbic acid mobilise Fe in vivo in Fe-loaded animals and this Fe acts as a catalyst for lipid peroxidation in the serum.
